Clinical protocol timeline showing PDRN polynucleotide treatment sequencing alongside fractional laser and energy device treatments

Combining PDRN with Laser and Energy Devices: Timing, Protocols, and Clinical Rationale

PDRN (polydeoxyribonucleotide) is one of the few injectable agents that is mechanistically well-matched to support this tissue response. Its adenosine A2A receptor activation drives the same wound healing cascade that laser and energy procedures initiate — but from the biological inside rather than through physical injury. The anti-inflammatory, pro-angiogenic, and fibroblast-stimulating effects of PDRN align precisely with what treated tissue needs in the recovery and remodelling phases after an energy procedure.